In view of the above, specifically of the possibility that LRH-1 could elicit an islet-driven anti-inflammatory microenvironment, we posited that upregulating LRH-1 activity could have beneficial therapeutic effects in diabetes mellitus (DM). Here, NR5A2 is linked to diabetes mellitus.